首页> 美国卫生研究院文献>Journal of Diabetes Investigation >Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus
【2h】

Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus

机译:阿卡波糖治疗可改善2型糖尿病患者的动脉僵硬度

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

>Aims/Introduction:  Although the improvement of postprandial hyperglycemia by an alpha‐glucosidase inhibitor (α‐GI) has been associated with a risk reduction of cardiovascular events, the relationship between postprandial hyperglycemia and arterial stiffness has not been well understood. We therefore examined whether ameliorating the postprandial state by α‐GI leads to an improvement in arterial stiffness.>Materials and Methods:  A total of 22 patients with type 2 diabetes mellitus were treated with acarbose. Cardio‐ankle vascular index (CAVI) as the arterial stiffness was measured by using a VaSera CAVI instrument before and 12 months after acarbose treatment. Serum high‐sensitivity C‐reactive protein (hs‐CRP), pentraxin‐3 (PTX3) and matrix metalloproteinase (MMP) ‐2, ‐9 were measured at the same time points. Furthermore, circulating peripheral blood mononuclear cells were examined for the frequencies of CD14 positive cells expressing membrane type‐1 MMP (MT1‐MMP) at the single cell level using flow cytometry.>Results:  After acarbose treatment, postprandial glucose and glycosylated hemoglobin (HbA1c) were significantly decreased. Serum levels of hs‐CRP, PTX3, MMP‐2 and MMP‐9 were significantly decreased. CAVI showed a significant reduction, although the changes were not significant in blood pressure and heart rate. MT1‐MMP expression was significantly decreased by acarbose treatment. In multivariate analysis, improvement of blood glucose, decrease of PTX3 levels and MT1‐MMP expression were independent predictors of beneficial change in CAVI.>Conclusions:  The present study showed that the beneficial effects of acarbose on arterial stiffness are mediated by an improvement of postprandial hyperglycemia and vascular remodeling markers. In conclusion, acarbose treatment might reduce the risk of cardiovascular diseases by altering the arterial stiffness in postprandial hyperglycemic status. >(J Diabetes Invest, doi:>, 2010)
机译:>目标/简介:尽管α-葡萄糖苷酶抑制剂(α-GI)改善了餐后高血糖与降低心血管事件的风险有关,但餐后高血糖与动脉僵硬度之间的关系尚未明确非常明白。因此,我们研究了通过α-GI改善餐后状态是否可以改善动脉僵硬度。>材料和方法:总共22例2型糖尿病患者接受了阿卡波糖治疗。在进行阿卡波糖治疗之前和之后12个月,使用VaSera CAVI仪器测量心踝血管指数(CAVI)作为动脉刚度。在相同的时间点测量血清高敏C反应蛋白(hs-CRP),pentraxin-3(PTX3)和基质金属蛋白酶(MMP)-2,-9。此外,使用流式细胞仪检测循环的外周血单个核细胞在单细胞水平上表达1型膜MMP(MT1-MMP)膜的CD14阳性细胞的频率。>结果:在阿卡波糖治疗后,餐后葡萄糖和糖基化血红蛋白(HbA1c)明显降低。血清hs-CRP,PTX3,MMP-2和MMP-9含量显着降低。 CAVI显着降低,尽管血压和心率变化不明显。阿卡波糖治疗显着降低MT1-MMP表达。在多变量分析中,血糖的改善,PTX3水平的降低和MT1-MMP表达是CAVI有益变化的独立预测因素。>结论:本研究表明,阿卡波糖对动脉僵硬度的有益作用是通过改善餐后高血糖和血管重塑标志物介导。总之,阿卡波糖治疗可通过改变餐后高血糖状态的动脉僵硬度来降低心血管疾病的风险。 >(J Diabetes Invest,doi: >,2010年)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号